79 related articles for article (PubMed ID: 19863224)
21. Cytokine mapping of sera from women with preeclampsia and normal pregnancies.
Jonsson Y; Rubèr M; Matthiesen L; Berg G; Nieminen K; Sharma S; Ernerudh J; Ekerfelt C
J Reprod Immunol; 2006 Jun; 70(1-2):83-91. PubMed ID: 16388854
[TBL] [Abstract][Full Text] [Related]
22. A phase-I trial using a universal GM-CSF-producing and CD40L-expressing bystander cell line (GM.CD40L) in the formulation of autologous tumor cell-based vaccines for cancer patients with stage IV disease.
Dessureault S; Noyes D; Lee D; Dunn M; Janssen W; Cantor A; Sotomayor E; Messina J; Antonia SJ
Ann Surg Oncol; 2007 Feb; 14(2):869-84. PubMed ID: 17103257
[TBL] [Abstract][Full Text] [Related]
23. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
[TBL] [Abstract][Full Text] [Related]
24. Comparative studies of tissue inhibitor of metalloproteinases-1 in plasma, serum and tumour tissue extracts from patients with primary colorectal cancer.
Sørensen NM; Schrohl AS; Jensen V; Christensen IJ; Nielsen HJ; Brünner N
Scand J Gastroenterol; 2008; 43(2):186-91. PubMed ID: 18224564
[TBL] [Abstract][Full Text] [Related]
25. Enzyme-linked immunospot, cytokine flow cytometry, and tetramers in the detection of T-cell responses to a dendritic cell-based multipeptide vaccine in patients with melanoma.
Whiteside TL; Zhao Y; Tsukishiro T; Elder EM; Gooding W; Baar J
Clin Cancer Res; 2003 Feb; 9(2):641-9. PubMed ID: 12576430
[TBL] [Abstract][Full Text] [Related]
26. IL-12p70 and IL-18 gene-modified dendritic cells loaded with tumor antigen-derived peptides or recombinant protein effectively stimulate specific Type-1 CD4+ T-cell responses from normal donors and melanoma patients in vitro.
Vujanovic L; Ranieri E; Gambotto A; Olson WC; Kirkwood JM; Storkus WJ
Cancer Gene Ther; 2006 Aug; 13(8):798-805. PubMed ID: 16645618
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer.
Yamamoto M; Kamigaki T; Yamashita K; Hori Y; Hasegawa H; Kuroda D; Moriyama H; Nagata M; Ku Y; Kuroda Y
Oncol Rep; 2009 Aug; 22(2):337-43. PubMed ID: 19578774
[TBL] [Abstract][Full Text] [Related]
28. Tissue inhibitor of metalloproteinases-1 in the postoperative monitoring of colorectal cancer.
Holten-Andersen MN; Nielsen HJ; Sørensen S; Jensen V; Brünner N; Christensen IJ
Eur J Cancer; 2006 Aug; 42(12):1889-96. PubMed ID: 16809030
[TBL] [Abstract][Full Text] [Related]
29. [Reduction of immunosuppression and shift to Th1 response by tumor-DC (dendritic cells) fusion vaccine].
Iinuma H; Okinaga K; Fukushima R; Inaba T; Iwasaki K; Arai T; Tamura J; Kumagai H
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1640-2. PubMed ID: 15553669
[TBL] [Abstract][Full Text] [Related]
30. Th1 and Th2 cytokine responses after measles antigen stimulation in vitro in bone marrow transplant patients: response to measles vaccination.
Pauksen K; Sjölin J; Linde A; Alm G; Andersson B; Lönnerholm G; Ljungman P
Bone Marrow Transplant; 1997 Aug; 20(4):317-23. PubMed ID: 9285547
[TBL] [Abstract][Full Text] [Related]
31. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
32. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
[TBL] [Abstract][Full Text] [Related]
33. A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment.
Liu KJ; Chao TY; Chang JY; Cheng AL; Ch'ang HJ; Kao WY; Wu YC; Yu WL; Chung TR; Whang-Peng J
J Biomed Sci; 2016 Aug; 23(1):64. PubMed ID: 27558635
[TBL] [Abstract][Full Text] [Related]
34. Multiplexed cytokine profiling of serum for detection of colorectal cancer.
Pengjun Z; Xinyu W; Feng G; Xinxin D; Yulan L; Juan L; Xingwang J; Zhennan D; Yaping T
Future Oncol; 2013 Jul; 9(7):1017-27. PubMed ID: 23837764
[TBL] [Abstract][Full Text] [Related]
35. CEA Plasmid as Therapeutic DNA Vaccination against Colorectal Cancer.
Veisi Malekshahi Z; Hashemi Goradel N; Shakouri Khomartash M; Maleksabet A; Kadkhodazadeh M; Kardar GA; Negahdari B
Iran J Immunol; 2019 Sep; 16(3):235-245. PubMed ID: 31552832
[TBL] [Abstract][Full Text] [Related]
36. Xenogeneic cell-based vaccine therapy for colorectal cancer: Safety, association of clinical effects with vaccine-induced immune responses.
Seledtsova GV; Shishkov AA; Kaschenko EA; Seledtsov VI
Biomed Pharmacother; 2016 Oct; 83():1247-1252. PubMed ID: 27565847
[TBL] [Abstract][Full Text] [Related]
37. Immunological parameters of candidiasis in cancer patients.
Magrys A; Koziol-Montewka M; Staroslawska E; Gabczynska B; Szczepanik A
New Microbiol; 2005 Oct; 28(4):355-64. PubMed ID: 16386020
[TBL] [Abstract][Full Text] [Related]
38. Association of serum and intratumoral cytokine profiles with tumor stage and neutrophil lymphocyte ratio in colorectal cancer.
Kim YW; Kim SK; Kim CS; Kim IY; Cho MY; Kim NK
Anticancer Res; 2014 Jul; 34(7):3481-7. PubMed ID: 24982357
[TBL] [Abstract][Full Text] [Related]
39. Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy.
Fong L; Brockstedt D; Benike C; Breen JK; Strang G; Ruegg CL; Engleman EG
J Immunol; 2001 Dec; 167(12):7150-6. PubMed ID: 11739538
[TBL] [Abstract][Full Text] [Related]
40. Serum cytokines in metastatic melanoma patients treated with an autologous tumor vaccine.
Schiltz PM; Dillman RO
Cancer Biother Radiopharm; 2003 Dec; 18(6):879-86. PubMed ID: 14969600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
